| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 143, 918-925, Copyright © 1993 by American Society for Investigative Pathology
REGULAR ARTICLES |
K Tsukidate, K Yamamoto, JW Snyder and JL Farber
Department of Pathology and Cell Biology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107-6799.
We investigated the mechanism of lethal injury following the disruption of microtubules in cultured hepatocytes treated with vinblastine (VBL) or colchicine (COL). These agents kill hepatocytes by a process readily distinguished from two well-known pathways that lead to a loss of viability, namely, oxidative stress and inhibition of mitochondrial electron transport. Cell killing with VBL and COL was accompanied by fragmentation of DNA. Both the loss of viability and the fragmentation of DNA were prevented by the inhibition of protein synthesis within 6 hours following exposure to VBL or COL. Cell death and the fragmentation of DNA were also prevented when Ca2+ was removed from the culture medium. By contrast, the inhibition of protein kinase C prevented cell killing by VBL or COL, but did not alter the extent of DNA fragmentation. The requirements here for protein synthesis, extracellular Ca2+, and protein kinase C activity define a model of apoptosis, or programmed cell death, that seems to involve mechanisms that can be dissociated from the fragmentation of DNA.
This article has been cited by other articles:
![]() |
J.-P. Therrien, W. Pfutzner, and J. C. Vogel An Approach to Achieve Long-Term Expression in Skin Gene Therapy Toxicol Pathol, January 1, 2008; 36(1): 104 - 111. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Zubenko, W. N. Zubenko, B. S. Maher, and N. S. Wolf Reduced Age-Related Cataracts Among Elderly Persons Who Reach Age 90 With Preserved Cognition: A Biomarker of Successful Aging? J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2007; 62(5): 500 - 506. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Benoff, C. Millan, I. R. Hurley, B. Napolitano, and J. L. Marmar Bilateral increased apoptosis and bilateral accumulation of cadmium in infertile men with left varicocele Hum. Reprod., March 1, 2004; 19(3): 616 - 627. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Pfutzner, A. Terunuma, C. L. Tock, E. K. Snead, T. M. Kolodka, M. M. Gottesman, L. Taichman, and J. C. Vogel Topical colchicine selection of keratinocytes transduced with the multidrug resistance gene (MDR1) can sustain and enhance transgene expression in vivo PNAS, October 1, 2002; 99(20): 13096 - 13101. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tezel and M. B. Wax The Mechanisms of hsp27 Antibody-Mediated Apoptosis in Retinal Neuronal Cells J. Neurosci., May 15, 2000; 20(10): 3552 - 3562. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lipton Ischemic Cell Death in Brain Neurons Physiol Rev, October 1, 1999; 79(4): 1431 - 1568. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-L. Hu, S. Li, J. Y.-J. Shyy, and S. Chien Sustained JNK activation induces endothelial apoptosis: studies with colchicine and shear stress Am J Physiol Heart Circ Physiol, October 1, 1999; 277(4): H1593 - H1599. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Mooberry, G. Tien, A. H. Hernandez, A. Plubrukarn, and B. S. Davidson Laulimalide and Isolaulimalide, New Paclitaxel-Like Microtubule-Stabilizing Agents Cancer Res., February 1, 1999; 59(3): 653 - 660. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. K. Goh, T. J. Pircher, and P. E. Lobie Growth Hormone Promotion of Tubulin Polymerization Stabilizes the Microtubule Network and Protects Against Colchicine-Induced Apoptosis Endocrinology, October 1, 1998; 139(10): 4364 - 4372. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. JANMEY The Cytoskeleton and Cell Signaling: Component Localization and Mechanical Coupling Physiol Rev, July 1, 1998; 78(3): 763 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Osborn and T. C. Chambers Role of the Stress-activated/c-Jun NH2-terminal Protein Kinase Pathway in the Cellular Response to Adriamycin and Other Chemotherapeutic Drugs J. Biol. Chem., November 29, 1996; 271(48): 30950 - 30955. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |